Most cancer patients want tumor profiling, even if it reveals other genetic risks

April 22, 2015 by Vicky Agnew, Yale University
Most cancer patients want tumor profiling, even if it reveals other genetic risks
Credit: Shutterstock

Most cancer patients would opt for tumor profiling even if the test revealed that they or their families were at risk for other genetic diseases, according to a Yale Cancer Center study. The findings were presented April 21 at the American Association for Cancer Research Annual Meeting 2015 in Philadelphia.

Increasingly sophisticated tumor profiling technology has led to advancements in diagnosing and treating like cancer. Yet, there is a downside to the cascade of data that a can uncover. Specifically, tests can uncover incidental findings about unrelated to the cancer that could—but not necessarily will—affect the patients or their relatives. These findings could include genetic variants that would predispose patients and their family to a variety of conditions including other cancers, Alzheimer's, and .

The study showed that despite the risk for receiving information about other potentially serious health problems, 59% of the would agree to tumor profiling if offered by their physician. In a scenario where tumor profiling was already ordered, 79% of patients stated they wanted to know all of the information obtained.

However, when specifically asked about a variety of possible incidental findings, only 57% wanted to know if they were found to have a gene variant that would cause an unpreventable and serious illness, and only 47% wanted to know about a gene variant of uncertain significance.

"While tumor profiling holds the promise of improved therapeutics through personalized medicine, it is important that both clinicians and patients discuss the possibilities of incidental findings prior to ordering the testing, as the findings can have serious implications for both the patient and their family members," said Dr. Melinda Yushak, first author on the study and a medical oncology fellow in Yale School of Medicine.

Despite the willingness by most patients to pursue genetic testing, patients differed widely in what they wanted to know about incidental findings. For instance, 18% of patients wanted to know only about the information obtained that would impact their cancer treatment; and 12% would not want to know about a genetic variant that could be inherited.

Explore further: Canadians' preferences for receiving incidental findings from genetic testing

Related Stories

Canadians' preferences for receiving incidental findings from genetic testing

March 9, 2015
Although many people value receiving information about incidental findings identified from genomic sequencing, not everyone wants to know about genetic conditions regardless of potential health implications, found a study ...

Liquid biopsy provides real-time blood test for solid lung cancer tumors

February 27, 2015
In the rapidly changing world of molecular profiling for genetic diseases, cancer researchers are increasingly optimistic about the reality of a simple blood test to monitor and treat solid tumor cancers.

A third of breast cancer patients concerned about genetic risk

April 6, 2015
A new study from the University of Michigan Comprehensive Cancer Center finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing ...

Tumor-only genetic sequencing may misguide cancer treatment in nearly half of all patients

April 15, 2015
A study by Johns Hopkins scientists strongly suggests that sequencing tumor genomes for clues to genetic changes might misdirect treatment in nearly half of all patients unless it is compared first to a genetic readout of ...

Gene signatures predict doxorubicin response in K9 osteosarcoma

April 20, 2015
There are two chemotherapies commonly used to treat bone cancer in dogs: doxorubicin and carboplatin. Some dogs respond better to one drug than to the other. But until now, the choice has been left largely to chance. New ...

New potential for personalized treatments in bowel cancer

March 22, 2015
Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today in the journal Oncoimmunology.

Recommended for you

Scientists reveal likely cause of childhood leukaemia

May 21, 2018
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.

Compound in citrus oil could reduce dry mouth in head, neck cancer patients

May 21, 2018
A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine.

Ice cream funds research showing new strategy against thyroid cancer

May 21, 2018
Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis. And standard treatment for the condition includes 7 weeks of radiation, often along with chemotherapy.

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.